SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]:
SEC Accession No. 0001213900-23-076255
Filing Date
2023-09-13
Accepted
2023-09-13 09:58:48
Documents
3
Period of Report
2023-09-13

Document Format Files

Seq Description Document Type Size
1 REPORT OF FOREIGN PRIVATE ISSUER ea184837-6k_clearmind.htm 6-K 10911
2 CONDENSED INTERIM CONSOLIDATED FINANCIAL STATEMENTS FOR THE THREE AND NINE MONTH ea184837ex99-1_clearmind.htm EX-99.1 312822
3 MANAGEMENT'S DISCUSSION AND ANALYSIS FOR THE FOR THE THREE AND NINE MONTHS ENDED ea184837ex99-2_clearmind.htm EX-99.2 271179
  Complete submission text file 0001213900-23-076255.txt   595935
Mailing Address 101-1220 WEST 6TH AVENUE VANCOUVER, BRITISH COLUMBIA Z4 V6H1A5
Business Address 101-1220 WEST 6TH AVENUE VANCOUVER, BRITISH COLUMBIA Z4 V6H1A5 972-54-5704749
Clearmind Medicine Inc. (Filer) CIK: 0001892500 (see all company filings)

IRS No.: 000000000 | State of Incorp.: Z4 | Fiscal Year End: 1031
Type: 6-K | Act: 34 | File No.: 001-41557 | Film No.: 231251753
SIC: 2834 Pharmaceutical Preparations